{"id":2416,"date":"2019-07-18T06:22:42","date_gmt":"2019-07-18T06:22:42","guid":{"rendered":"http:\/\/www.sci.muni.cz\/ofiz\/?p=2416"},"modified":"2020-05-12T09:00:21","modified_gmt":"2020-05-12T09:00:21","slug":"interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia","status":"publish","type":"post","link":"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/","title":{"rendered":"Interview with Vitezslav Bryja about developing CK1 inhibitors for treatment of chronic lymphocytic leukemia"},"content":{"rendered":"\n

Masaryk University Technology Transfer Office prepared an\ninterview with Vitezslav Bryja about developing inhibitors of casein kinase 1\nin collaboration with Kamil Paruch\u00b4s group (Department of Chemistry) that can\nbe used in the future as treatment of chronic lymphocytic leukemia and\npotentially also of other diseases.<\/p>\n\n\n\n

Read the interview here: https:\/\/www.ctt.muni.cz\/en\/news\/interface\/articles\/i-peeked-into-a-world-that-was-hidden-to-me-says-vitezslav-bryja <\/a><\/p>\n\n\n\n

\"\"<\/figure>\n","protected":false},"excerpt":{"rendered":"

Masaryk University Technology Transfer Office prepared an interview with Vitezslav Bryja about developing inhibitors of casein kinase 1 in collaboration with Kamil Paruch\u00b4s group (Department of Chemistry) that can be used in the future as treatment of chronic lymphocytic leukemia … Read More<\/a><\/p>\n","protected":false},"author":5,"featured_media":2414,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"kt_blocks_editor_width":"","_exactmetrics_skip_tracking":false,"footnotes":""},"categories":[412,267],"tags":[304],"class_list":["post-2416","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bryjalab","category-news","tag-bryjalab"],"yoast_head":"\nInterview with Vitezslav Bryja about developing CK1 inhibitors for treatment of chronic lymphocytic leukemia - Department of Animal Physiology and Immunology<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Interview with Vitezslav Bryja about developing CK1 inhibitors for treatment of chronic lymphocytic leukemia - Department of Animal Physiology and Immunology\" \/>\n<meta property=\"og:description\" content=\"Masaryk University Technology Transfer Office prepared an interview with Vitezslav Bryja about developing inhibitors of casein kinase 1 in collaboration with Kamil Paruch\u00b4s group (Department of Chemistry) that can be used in the future as treatment of chronic lymphocytic leukemia … Read More\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/\" \/>\n<meta property=\"og:site_name\" content=\"Department of Animal Physiology and Immunology\" \/>\n<meta property=\"article:published_time\" content=\"2019-07-18T06:22:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-05-12T09:00:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ueb1.sci.muni.cz\/ofiz\/wp-content\/uploads\/2019\/07\/vita1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"723\" \/>\n\t<meta property=\"og:image:height\" content=\"1085\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lucie Nesvadbov\u00e1\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lucie Nesvadbov\u00e1\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/\"},\"author\":{\"name\":\"Lucie Nesvadbov\u00e1\",\"@id\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/#\/schema\/person\/3119766c8e4c78f08bbbde220469aee6\"},\"headline\":\"Interview with Vitezslav Bryja about developing CK1 inhibitors for treatment of chronic lymphocytic leukemia\",\"datePublished\":\"2019-07-18T06:22:42+00:00\",\"dateModified\":\"2020-05-12T09:00:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/\"},\"wordCount\":74,\"publisher\":{\"@id\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/#organization\"},\"image\":{\"@id\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/wp-content\/uploads\/2019\/07\/vita1.jpg\",\"keywords\":[\"Bryjalab\"],\"articleSection\":[\"Bryjalab\",\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/\",\"url\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/\",\"name\":\"Interview with Vitezslav Bryja about developing CK1 inhibitors for treatment of chronic lymphocytic leukemia - Department of Animal Physiology and Immunology\",\"isPartOf\":{\"@id\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/wp-content\/uploads\/2019\/07\/vita1.jpg\",\"datePublished\":\"2019-07-18T06:22:42+00:00\",\"dateModified\":\"2020-05-12T09:00:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/#primaryimage\",\"url\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/wp-content\/uploads\/2019\/07\/vita1.jpg\",\"contentUrl\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/wp-content\/uploads\/2019\/07\/vita1.jpg\",\"width\":723,\"height\":1085},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Interview with Vitezslav Bryja about developing CK1 inhibitors for treatment of chronic lymphocytic leukemia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/#website\",\"url\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/\",\"name\":\"Department of Animal Physiology and Immunology\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/#organization\",\"name\":\"Department of Animal Physiology and Immunology\",\"url\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.sci.muni.cz\/ofiz\/wp-content\/uploads\/2019\/02\/logo_EN.png\",\"contentUrl\":\"https:\/\/www.sci.muni.cz\/ofiz\/wp-content\/uploads\/2019\/02\/logo_EN.png\",\"width\":1903,\"height\":264,\"caption\":\"Department of Animal Physiology and Immunology\"},\"image\":{\"@id\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/#\/schema\/person\/3119766c8e4c78f08bbbde220469aee6\",\"name\":\"Lucie Nesvadbov\u00e1\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a91adf81f15a662a55b84fac48c8a8a4f22879e0ab9141bb8487b53bb898b6a6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a91adf81f15a662a55b84fac48c8a8a4f22879e0ab9141bb8487b53bb898b6a6?s=96&d=mm&r=g\",\"caption\":\"Lucie Nesvadbov\u00e1\"},\"url\":\"https:\/\/ueb1.sci.muni.cz\/ofiz\/author\/nesvadbova\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Interview with Vitezslav Bryja about developing CK1 inhibitors for treatment of chronic lymphocytic leukemia - Department of Animal Physiology and Immunology","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/","og_locale":"en_US","og_type":"article","og_title":"Interview with Vitezslav Bryja about developing CK1 inhibitors for treatment of chronic lymphocytic leukemia - Department of Animal Physiology and Immunology","og_description":"Masaryk University Technology Transfer Office prepared an interview with Vitezslav Bryja about developing inhibitors of casein kinase 1 in collaboration with Kamil Paruch\u00b4s group (Department of Chemistry) that can be used in the future as treatment of chronic lymphocytic leukemia … Read More","og_url":"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/","og_site_name":"Department of Animal Physiology and Immunology","article_published_time":"2019-07-18T06:22:42+00:00","article_modified_time":"2020-05-12T09:00:21+00:00","og_image":[{"width":723,"height":1085,"url":"https:\/\/ueb1.sci.muni.cz\/ofiz\/wp-content\/uploads\/2019\/07\/vita1.jpg","type":"image\/jpeg"}],"author":"Lucie Nesvadbov\u00e1","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Lucie Nesvadbov\u00e1"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/#article","isPartOf":{"@id":"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/"},"author":{"name":"Lucie Nesvadbov\u00e1","@id":"https:\/\/ueb1.sci.muni.cz\/ofiz\/#\/schema\/person\/3119766c8e4c78f08bbbde220469aee6"},"headline":"Interview with Vitezslav Bryja about developing CK1 inhibitors for treatment of chronic lymphocytic leukemia","datePublished":"2019-07-18T06:22:42+00:00","dateModified":"2020-05-12T09:00:21+00:00","mainEntityOfPage":{"@id":"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/"},"wordCount":74,"publisher":{"@id":"https:\/\/ueb1.sci.muni.cz\/ofiz\/#organization"},"image":{"@id":"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/#primaryimage"},"thumbnailUrl":"https:\/\/ueb1.sci.muni.cz\/ofiz\/wp-content\/uploads\/2019\/07\/vita1.jpg","keywords":["Bryjalab"],"articleSection":["Bryjalab","News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/","url":"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/","name":"Interview with Vitezslav Bryja about developing CK1 inhibitors for treatment of chronic lymphocytic leukemia - Department of Animal Physiology and Immunology","isPartOf":{"@id":"https:\/\/ueb1.sci.muni.cz\/ofiz\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/#primaryimage"},"image":{"@id":"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/#primaryimage"},"thumbnailUrl":"https:\/\/ueb1.sci.muni.cz\/ofiz\/wp-content\/uploads\/2019\/07\/vita1.jpg","datePublished":"2019-07-18T06:22:42+00:00","dateModified":"2020-05-12T09:00:21+00:00","breadcrumb":{"@id":"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/#primaryimage","url":"https:\/\/ueb1.sci.muni.cz\/ofiz\/wp-content\/uploads\/2019\/07\/vita1.jpg","contentUrl":"https:\/\/ueb1.sci.muni.cz\/ofiz\/wp-content\/uploads\/2019\/07\/vita1.jpg","width":723,"height":1085},{"@type":"BreadcrumbList","@id":"https:\/\/ueb1.sci.muni.cz\/ofiz\/en\/interview-with-vitezslav-bryja-about-developing-ck1-inhibitors-for-treatment-of-chronic-lymphocytic-leukemia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ueb1.sci.muni.cz\/ofiz\/"},{"@type":"ListItem","position":2,"name":"Interview with Vitezslav Bryja about developing CK1 inhibitors for treatment of chronic lymphocytic leukemia"}]},{"@type":"WebSite","@id":"https:\/\/ueb1.sci.muni.cz\/ofiz\/#website","url":"https:\/\/ueb1.sci.muni.cz\/ofiz\/","name":"Department of Animal Physiology and Immunology","description":"","publisher":{"@id":"https:\/\/ueb1.sci.muni.cz\/ofiz\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ueb1.sci.muni.cz\/ofiz\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ueb1.sci.muni.cz\/ofiz\/#organization","name":"Department of Animal Physiology and Immunology","url":"https:\/\/ueb1.sci.muni.cz\/ofiz\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ueb1.sci.muni.cz\/ofiz\/#\/schema\/logo\/image\/","url":"https:\/\/www.sci.muni.cz\/ofiz\/wp-content\/uploads\/2019\/02\/logo_EN.png","contentUrl":"https:\/\/www.sci.muni.cz\/ofiz\/wp-content\/uploads\/2019\/02\/logo_EN.png","width":1903,"height":264,"caption":"Department of Animal Physiology and Immunology"},"image":{"@id":"https:\/\/ueb1.sci.muni.cz\/ofiz\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ueb1.sci.muni.cz\/ofiz\/#\/schema\/person\/3119766c8e4c78f08bbbde220469aee6","name":"Lucie Nesvadbov\u00e1","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ueb1.sci.muni.cz\/ofiz\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a91adf81f15a662a55b84fac48c8a8a4f22879e0ab9141bb8487b53bb898b6a6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a91adf81f15a662a55b84fac48c8a8a4f22879e0ab9141bb8487b53bb898b6a6?s=96&d=mm&r=g","caption":"Lucie Nesvadbov\u00e1"},"url":"https:\/\/ueb1.sci.muni.cz\/ofiz\/author\/nesvadbova\/"}]}},"_links":{"self":[{"href":"https:\/\/ueb1.sci.muni.cz\/ofiz\/wp-json\/wp\/v2\/posts\/2416","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ueb1.sci.muni.cz\/ofiz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ueb1.sci.muni.cz\/ofiz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ueb1.sci.muni.cz\/ofiz\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/ueb1.sci.muni.cz\/ofiz\/wp-json\/wp\/v2\/comments?post=2416"}],"version-history":[{"count":2,"href":"https:\/\/ueb1.sci.muni.cz\/ofiz\/wp-json\/wp\/v2\/posts\/2416\/revisions"}],"predecessor-version":[{"id":2419,"href":"https:\/\/ueb1.sci.muni.cz\/ofiz\/wp-json\/wp\/v2\/posts\/2416\/revisions\/2419"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ueb1.sci.muni.cz\/ofiz\/wp-json\/wp\/v2\/media\/2414"}],"wp:attachment":[{"href":"https:\/\/ueb1.sci.muni.cz\/ofiz\/wp-json\/wp\/v2\/media?parent=2416"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ueb1.sci.muni.cz\/ofiz\/wp-json\/wp\/v2\/categories?post=2416"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ueb1.sci.muni.cz\/ofiz\/wp-json\/wp\/v2\/tags?post=2416"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}